(Reuters) – Europe’s medicines regulator has added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side–effect of AstraZeneca‘s COVID–19 vaccine, regular safety updates from the watchdog showed on Wednesday. The European Medicines Agency said a causal relationship between GBS…